Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms

European Journal of Cancer

Volumn 44, Issue 15, 2008, Pages 2254-2258

  Dancourt, Vincent ^a   Lejeune, Catherine ^a   Lepage, Côme ^a   Gailliard, Marie Claude ^b   Meny, Bernard ^a   Faivre, Jean ^a  

^a Chu   (France)

^b Centres d'Examens de Santé   (France)

Author keywords

Colorectal adenoma; Colorectal cancer; Faecal occult blood test; Guaiac test; Immunochemical test; Screening

Indexed keywords

GUAIAC;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PATHOLOGY; POPULATION BASED CASE CONTROL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADENOMA; AGE DISTRIBUTION; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; FRANCE; GUAIAC; HUMANS; INDICATORS AND REAGENTS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; SEX DISTRIBUTION;

EID: 53249093702     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.06.041     Document Type: Article

References (24)

1. Faivre J., Dancourt V., Lejeune C., et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 126 (2004) 1674-1680
2. Hardcastle J.D., Chamberlain J.O., Robinson M.H., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 348 (1996) 1472-1477
3. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
4. Mandel J.S., Bond J.H., Church T.R., et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328 (1993) 1365-1371
5. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
6. Boyle P., Autier P., Bartelink H., et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14 7 (2003) 973-1005
7. Advisory Committee on Cancer Prevention. Recommendations on cancer screening in the European union. Eur J Cancer 2000;36:1473-8.
8. Official Journal of the European Union. Council recommendations of 2 December 2003 on cancer screening. 2003;878EC(L327):34-38.
9. Castiglione G., Sala P., Ciatto S., et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev 3 (1994) 399-405
10. Greenberg P.D., Bertario L., Gnauck R., et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 95 (2000) 1331-1338
11. Hoepffner N., Shastri Y.M., Hanisch E., et al. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Aliment Pharmacol Ther 23 (2006) 145-154
12. Hugues K., Leggett B., Del Mar C., et al. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z Public Health 29 (2005) 358-364
13. Ko C., Dominitz J., and Nguyen T. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med 2 (2003) 111-114
14. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146 (2007) 244-255
15. Smith A., Young G., Cole S., and Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107 (2006) 2152-2159
16. Allison J.E., Sakoda L.C., Levin T.R., et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99 (2007) 1462-1470
17. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56 (2007) 210-214
18. Segnan N., Senore C., Andreoni B., et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132 (2007) 2304-2312
19. Arrêté du 29 septembre 2006 relatif aux programmes de dépistage des cancers: Journal Officiel, Paris; 2006.
20. Sobin L, Fleming I. TNM classification of malignant tumors. fifth ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
21. Wilson J, Junger Y. Principles and practice of mass screening for disease. Public Health Papers 34; Geneva: WHO, 1968.
22. Vilkin A., Rozen P., Levi Z., et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100 (2005) 2519-2525
23. UK Colorectal Cancer Screening Pilot Group. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 329 (2004) 133
24. Federici A., Giorgi Rossi P., Borgia P., et al. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen 12 (2005) 83-88